Related Experiment Video
Updated: May 28, 2026

08:40
Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
Published on: November 29, 2016
[ERK and P38MAPK expressions and human sperm motility]
Yu-Qin Ding1, Hong Jiang, Cun-Li Wang
1Reproductive Medicine Center, The PLA Clinical Medical School Affiliated to Anhui Medical University, Hefei, Anhui 230031, China.
Zhonghua Nan Ke Xue = National Journal of Andrology
|October 4, 2011
Summary
In males with asthenospermia (impaired sperm motility), extracellular-signal regulated protein kinase (ERK) and P38 mitogen activated protein kinase (P38 MAPK) protein expression increased. P38 MAPK phosphorylation also rose, suggesting a role in sperm dysfunction.
Area of Science:
- Molecular Biology
- Reproductive Biology
- Biochemistry
Context:
- Asthenospermia, characterized by reduced sperm motility, is a significant factor in male infertility.
- Extracellular-signal regulated protein kinase (ERK) and P38 mitogen activated protein kinase (P38 MAPK) are key signaling molecules implicated in cellular processes.
- Understanding the role of these kinases in sperm function is crucial for diagnosing and treating male infertility.
Purpose:
- To investigate the differential expression and phosphorylation of ERK and P38 MAPK in spermatozoa from healthy individuals and males with asthenospermia.
- To determine the correlation between ERK and P38 MAPK levels and sperm motility parameters.
Summary:
- Western blotting analysis revealed significantly elevated protein expression of both ERK and P38 MAPK in asthenospermia group compared to controls.
- A significant increase in P38 MAPK phosphorylation was observed in asthenospermia group, while ERK phosphorylation showed no significant difference.
- These findings indicate altered kinase activity in spermatozoa associated with impaired sperm motility.
Impact:
- The study suggests that up-regulated ERK and P38 MAPK expression, along with increased P38 MAPK phosphorylation, may contribute to the pathophysiology of asthenospermia.
- These molecular alterations could serve as potential biomarkers for diagnosing asthenospermia.
- Further research into these pathways may reveal novel therapeutic targets for male infertility.

